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ABSTRACT 
Higher exposure to light at night per se and through decrease in sleep duration and night 
shift work may suppress serum melatonin levels, which in turn may increase the reproductive 
hormone levels. High levels of steroid hormones, especially estrogens, may be associated with 
an increase of the breast cancer risk. 
This  study  investigated  whether  variation  in  the  sleep  duration  during  one  entire 
menstrual  cycle  corresponds  to  variation  in  estradiol  levels  in  healthy,  urban  women  of 
reproductive age. Ninthy five regularly menstruating women ages 24-36 collected daily saliva 
samples for one entire menstrual cycle and recorded the number of hours of sleep per night 
(sleep duration). Saliva samples were analyzed for concentration of 17-ß estradiol (E2).  
We documented, after adjustments for sleep duration, a positive relationship between 
the sleep variation (coefficient of variation in sleep duration - sleep CV) and estradiol levels 
in women of reproductive age. Mean levels of E2 differed significantly in women from the 
lowest sleep CV quartile in comparison to other quartiles (p<0.001). The low sleep variation 
group, that is the women who sleep regularly, had mean E2 levels 60% lower than other 
groups. These results suggest that sleep variation significantly correlates with E2 levels, while 
sleep duration does not show a statistically significant relationship. According to the breast 
cancer  development  hypothesis,  increasing  the  lifetime  exposure  to  endogenous  estrogens 
could result in higher risk of breast cancer. 
 
INTRODUCTION 
Sleep  duration  and  night  shift  work  are  related  to  many  aspects  of  health,  possibly 
including reproduction and risk of breast cancer in women (Davis et al., 2001; Hansen, 2001; Schernhammer et al., 2001). Higher exposure to light at night per se and through decrease in 
sleep duration and night shift work may suppress serum melatonin levels, which in turn may 
increase  the  reproductive  hormone  levels  (Cohen  et  al.,  1978;  Okatani,  et  al.,  2000; 
Schernhammer et al., 2004). Women exposure to steroid hormones, especially estrogens, may 
be associated with an increase of the breast cancer risk (Cauley at al., 1999; Eliassen et al., 
2006; Hankinson et al., 1998; Jasienska and Thune, 2001; Missmer et al., 2004; Yu et al., 
2003). 
  Melatonin, a hormone released mainly by pineal gland, whose synthesis and secretion 
are stimulated by darkness and inhibited by light (Tamarkin et al., 1985, Malpaux, et al., 
2001).  The  connection  between  melatonin  production  and  estradiol  levels  has  been  well 
established (Brzezinski, 1987, 1988; Yie, 1995; Okatani et al., 2000; Shernhammer et al., 
2004). Seasonal variation in daylight has been shown to relate to ovarian function. When 
melatonin and ovarian activity were measured in a region with a strong seasonal contrast in 
luminosity (Kauppila et al., 1987) the daytime 12-h melatonin index and daytime urinary 
melatonin excretion were significantly higher in dark season than during the light season, and 
was accompanied by decreased mean serum estradiol concentration at the time of ovulation 
and  during  the  luteal  phase  of  the  cycle,  indicating  lowered  ovarian  activity.  Seasonal 
difference in ovarian hormones concentrations was also reported by a study on joggers and 
runners (Ronkainen et al., 1985). Women had lower levels of estradiol, progesterone and 
testosterone in the dark season than in the light season. Similarly, estradiol concentrations 
were significantly lower during autumn and winter months, than during light months (264.7 ± 
44.1 and 661.8 ± 55.1 nmol/l respectively) when measured in follicular fluid samples which 
were  obtained  from  the  largest  pre-ovulatory  follicle  of  120  women  undergoing  in-vitro 
fertilization (Yie et al., 1995). The melatonin concentration in follicular fluid was also higher 
during the dark season than during the light season (Ronnberg et al., 1990). 
We investigated  whether variation in the  sleep  duration during one entire menstrual 
cycle corresponds to variation in estradiol (E2) levels in healthy urban women of reproductive 
age.  
 
MATERIALS AND METHODS 
Study participants 
One hundred and thirty six Polish urban women between 24 and 35 years of age (mean 
age 29.5 years, std. dev. 3.13) were recruited for the study by advertisements between June 
2001 and June 2003. Participants of the study were selected if they met the following criteria: regular menstrual cycles and no fertility problems, no gynecological and chronic disorders 
(i.e. diabetes,  hypo/hyperthyroidism), not taking any hormonal medication or using hormonal 
contraception  during  the  6  months  before  recruitment,  and  not  having  been  pregnant  or 
lactating during the 6 months before recruitment. Mean length of menstrual  cycle during 
which saliva samples were collected was 28.9 days (std. dev. 3.83 , range of 22–39 ). 
Out of 136 urban women who collected saliva samples for an entire menstrual cycle, 
95 participants were included in the main analysis: sleep duration data were not collected for 
32 women, and reliable identification of the day of the mid-cycle E2 drop could not be made 
for  9  participants.  The  research  protocol  was  approved  by  the  Jagiellonian  University 
Bioethical Committee. 
 
Sleep and estradiol measurements 
Information  on  average  number  of  hours  of  sleep  per  night  (sleep  duration)  was 
collected daily by questionnaires for one entire menstrual cycle. During the same menstrual 
cycle women collected daily morning saliva samples. Saliva samples from 20 days (reverse 
cycle days – 5 to – 24) of each cycle were analyzed for the concentration of E2 using an I-
125-based radiomunoassay kit (#39100, Diagnostic Systems Laboratories, Webster, Texas, 
USA) with published (Jasienska et al., 2004) modifications to the manufacturer’s protocol. 
Before statistical analyses, cycles were aligned on the basis of identification of the day of the 
midcycle estradiol drop (day 0), which provides a reasonable estimate of the day of ovulation, 
according to the published methods (Lipson and Ellison, 1996). The mean E2 values from 18 
consecutive days of each cycle aligned on day 0 was used in analysis.  
 
Anthropometric measurements, physical activity, dietary and general questionnaires 
A detailed description of anthropometric measurements and assessment of physical 
activity was published previously Jasienska et al. (2004, 2006). Average daily energy intake 
(kcal/day) was assessed by 24-h precoded food diary, in which women recorded the type and 
the portion size of every food item consumed during 24 hours on seven selected days in the 
menstrual cycle (days 3-6 and days 21-23) (Furberg et al., 2005). An album showing portions 
of products and meals was used by each women to estimate consumed amounts. From the 24-
h food diary, the total energy content of the daily food rations was calculated using the Dieta 
2 (version 1.1.) computer software (Institute of Food and Nutrition, Warsaw, Poland). Information on birth weight, education, reproductive history, past use of hormonal 
medication and tobacco was collected by a general questionnaire (partly administered by an 
interviewer and partly self-reported).  
 
Statistical analysis 
Variation  in  sleep  duration  for  each  woman  individually  was  calculated  as  the 
coefficient of variation in sleep duration (sleep CV). Low sleep CV value means that a similar 
number of hours of sleep each night was recorded during menstrual cycle, whilst high sleep 
CV value represents irregularity in circadian rhythm.  
Women  were  divided  into  quartiles  based  on  the  coefficient  of  variation  (CV).  
Differences among sleep CV groups in potentially confounding factors such as age, birth 
weight, height, energy intake, physical activity, body composition variables (body weight, 
body mass index, percentage of body fat) and mean duration of daylight for sample collection 
month were tested in separate one-way ANOVA analyses with sleep CV as grouping variable. 
Potential differences among the study groups in the mean duration of daylight were tested in 
order to control for the confounding effect on seasonality on estradiol levels. Differences 
between parous and nulliparous women in sleep CV were tested by Student’s t-test (sleep CV 
were  logarithmically  transformed  to  correct  the  skewness  of  distributions  and  used  as 
dependent variable in Student’s t-test). 
In order to test if quartiles of sleep CV differ in sleep duration we performed ANOVA 
analysis with group division criterion as one factor and mean sleep duration as dependent 
variable,  followed  by  contrasts  analysis.  An     level  of    0.0083  (with  the  Bonferroni 
correction) was used to indicate statistical significance. The effect of sleep CV on E2 levels 
was tested by one-way ANOVA analysis with the same group division criterion as one factor 
and  mean  E2  levels  as  dependent  variable.  Because  it  was  noticed  that  sleep  quality  is 
associated with E2 (Hollander at al., 2001) and sleep duration may have an influence on the 
breast cancer risk (Vercasalo, et al., 2005, Mc Elroy et al., 2006), possibly via affecting levels 
of ovarian hormones, we repeated analysis of covariance with mean sleep duration as the 
covariate. Covariance analysis was followed by contrasts analysis with an   level of 0.0125 
(with the Bonferroni correction) used to indicate statistical significance. For other analyses, 
the null hypothesis was rejected at the 0.05 level. Statistical analyses were performed with 
Statistica (version 7.1). 
 
RESULTS General characteristics of the sample 
General characteristics of all study subjects and the four groups divided by sleep CV are 
shown in Table 1. The women from groups with low, moderate, high and very high sleep CV 
did  not  differ  in  age,  birth  weight,  education,  energy  intake,  physical  activity,  smoking, 
height,  body  composition  (weight,  body  fat,  BMI),  reproductive  factors  (menarcheal  age, 
length of menstrual cycle) and mean duration of daylight. Similarly, there was no statistically 
significant difference in sleep CV between parous (n=41) and nulliparous (n=62) women (t-
test=-0.863,  p=0.390).  However,  four  groups  of  women  with  different  sleep  CV  show 
significant variation in sleep duration (F3,100=7.210, p<0.001). The group with very high sleep 
CV  had  shorter  sleep  duration  than  low  and  moderate  sleep  CV  groups  (F1,100=17.591, 
p<0.001; F1,100=13.294, p<0,001; respectively), (Fig.1). 
 
Table 1. Characteristics of all study participants and of four groups differing in sleep CV 
 
* variable log-transformed and used as dependent variable in one-way Anova 
 
All women 
 
 
Low sleep CV 
group 
N=25 
Moderate sleep CV  
group 
N=22 
High sleep CV  
group 
N=25 
Very high sleep CV  
group 
N=23 
Signifi
cance 
p for 
trend 
F 
  Mean  Std.Dev.  Mean  Std.Dev.  Mean  Std.Dev.  Mean  Std.Dev.  Mean  Std.Dev.     
Age (years)  29.48  3.131  31.04  3.180  28.95  3.373  30.17  3.036  29.48  3.016  0.113  F 3,99= 2.045 
Birth weight (g)  3320.02  627.809  3246.67  534.353  3181.68  807.492  3391.11  512.305  3323.33  755.552  0.723  F 3,81= 0.443 
Education total 
(years)* 
16.60  2.720  16.57  2.701  16.89  3.266  16.21  2.516  16.32  2.850  0.928  F 3,98=0.150 
Energy intake (kcal)*  1937.25  508.472  1985.77  566.829  1994.03  575.674  1809.90  403.033  2004.09  312.444  0.317  F 3,97=1.190 
Physical activity 
(MET-hour/day)* 
30.56  8.185  28.71  5.016  31.34  8.406  31.55  9.877  30.72  8.719  0.671  F 3,100 =0.520 
Body height (cm)*  164.24  6.07  163.14  5.671  163.85  5.664  164.71  6.057  165.22  6.939  0.629  F 3,100=1.000 
Body weight (kg)*  60.06  8.867  57.69  7.500  60.72  9.171  61.91  8.694  59.94  10.019  0.347  F 3,99=1.110 
Body fat (%)  25.78  6.822  24.87  6.408  25.99  7.374  26.94  6.34  25.26  7.458  0.703  F 3,98=0.471 
Body mass index 
(kg/m
2)* 
22.18  2.885  21.71  2.938  22.61  3.239  22.78  2.67  21.93  3.110  0.428  F 3,100=0.930 
Age at menarche 
(years)* 
13.30  1.384  13.24  1.422  13.61  1.447  13.22  1.265  13.44  1.502  0.742  F 3,97=0.420 
Length of menstrual 
cycle during sample 
collection (days)* 
28.88  3.831  27.41  3.153  29.30  3.878  28.59  4.247  29.84  3.496  0.098  F 2,101=0.240 
Mean duration of 
daylight (% of 24h) 
0.56  0.058  0.56  0.050  0.57  0.050  0.55  0.063  0.56  0.068  0.870  F 3,98=0.238 
Sleep CV (%)  16.00  5.460  10.09  1.358  13.78  0.775  16.81  1.333  23.44  4.588  <0.001  F 
3,100=132.775 
Sleep duration 
(h/day) 
7.44  0.689  7.74  0.497  7.67  0.671  7.35  0.610  7.00  0.749  <0.001  F 3,100=7.210 
Mean E2  
(from -9 to +8) 
(pmol/l)* 
20.10  11.318  13.93  6.626  25.11  10.617  21.92  11.639  20.03  13.111  <0.001  F 3,91=5.938 low moderate high very high
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Fig.1. Mean (with 95% confidence intervals) sleep duration (h/day) in groups of women with 
low, moderate, high and very high sleep variation. 
 
Sleep CV and mean sleep duration  
Average coefficient of variation (sleep CV) among study participants was 16.0% (std. 
dev.=5.5%) and sleep CV ranged from 7.54% to 37.45%. The sleep duration varied from 4.76 
to  9.28  hours.  The  average  sleep  duration  was  7.44  h/day  (std.  dev.=0.689)  and  was 
comparable to the average duration of sleep noted in representative Polish population sample 
of 47 924 adults over 15 years of age equaled 7.7 h (7.61–7.73 h) (Kiejna et al., 2004). The 
majority of subjects  in our study (63 of 104, or 60.6%) reported sleep duration between 7-8 
h/day. Average sleep duration of less or equal 7 h/day was reported by 24.03% of women,  
whereas 15.38% of women reported sleeping above 8 h/day.  
 
Estradiol levels and sleep CV 
One-way ANOVA analysis with mean E2 levels as dependent variable, revealed that 
four groups of women with different sleep variation differ in mean E2 levels (F3,91=5.938, 
p<0.001). Because sleep duration may also influence the estradiol levels, we conducted the 
covariance  analysis  stratified  by  sleep  CV  with  mean  sleep  duration  as  the  covariate. 
Variation in E2 levels among the four quartiles of sleep CV remained statistically significant 
(F3,87=3.102, p<0.05). The impact of sleep duration on mean E2 levels was not significant 
(F1,87=2.462, p=0.12), while the interaction between sleep CV and sleep duration approach 
borderline significance (F3,87=2.582, p for interaction =0.059).Contrast analysis indicated that 
group  of  women  characterized  by  low  sleep  variation  had  significantly  lower  E2  levels 
(F1,87=15.970, p<0.001) than all other groups of women (Fig.2).    Sleep CV - other
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Fig. 2.  
Mean (with 95% confidence intervals) profile of estradiol for group of women with low sleep 
variation and other (moderate, high and very high) groups combined.   
 
DISCUSSION 
We documented, after adjustments for sleep duration, a positive relationship between 
the sleep variation and estradiol levels in women of reproductive age. Mean levels of E2 
differed significantly in women from the lowest sleep CV quartile in comparison to other 
quartiles. The low sleep variation group, that is the women who sleep regularly, had mean E2 
levels 60% lower than other groups. We also noticed that the low sleep variation group slept 
10.6% longer than the very high variation group (7.7 h/day versus 7.0 h/day).     
These  results  suggest  that  sleep  duration  is  not  as  important  as  variation  in  sleep 
duration.  Irregularity  in  sleep  duration  is  associated  with  an  increase  in  the  E2  levels. 
According to the breast cancer development hypothesis, increasing the lifetime exposure to 
endogenous estrogens could result in higher risk of breast cancer. 
There  is  wide-spread  agreement  for the  idea  of  circadian  disruption  associated  with 
artificial lighting as the risk factor of the breast cancer incidence in the industrialized world 
(Stevens, 2006). Observational studies on shift workers having elevated breast cancer risk 
(Davis et al., 2001; Hansen, 2001; Schernhammer et al., 2001), suggest that not only sleep 
duration, but also sleep variation may play a role in breast cancer etiology. However, the 
association between variation in sleep duration and estradiol levels has not been previously 
documented.  One  study  documented  the  association  of  lower  E2  levels  with  poor  sleep 
(Hollander  et  al.,  2001).  However  poor  sleep  quality  among  women  aged  45-49  (late reproductive age) may not be comparable with sleep irregularity of women ages 24-36 and 
self-reported questionnaire used to describe insomnia may not correspond to the sleep CV. 
Besides ovarian steroids, we did not measure other hormones in this study, so we were 
not  able  to  test  the  mechanisms  responsible  for  the  link  between  sleep  CV  and  E2 
concentrations. However, melatonin secretion which decrease when people are exposed to 
light at night (Lewy et al., 1980) may play a role in observed relationship. Switching human 
volunteers  from  8-hour  night  to  14-hour  night  results  in  longer  duration  of  nocturnal 
melatonin  secretion  (Wehr,  1991),  but  it  is  not  known  weather  melatonin  production  is 
dependent on individual sleep variation.  
Other mechanisms may also be responsible for the observed relationship between sleep 
and estradiol concentrations. Short sleep duration was found to be associated with reduction 
of leptin and elevation of ghrelin (Taheri et al., 2004), that is likely to increase appetite. 
Leptin, besides its role in body weight (body fat stores) regulation, may be considered an 
endocrine mediator. Leptin itself exerts effects on different endocrine axes, mainly on the 
hypothalamic-pituitary-gonadal  axis  (Wauters  et  al.,  2000).  Both  in  vitro  and  in  vivo 
experimental evidence indicate that a link between leptin and ovarian steroids exists, but the 
mechanisms  have  not  been  clearly  understood.  Nonetheless,  it  was  found  that  in  normal 
weight premenopausal women serum leptin concentrations positively correlated with estradiol 
and were higher in the luteal than in the follicular phase, with a significant pre-ovulatory peak 
(Cella et al., 2000; Mannucci et al., 1998).  
Moreover, sleep disturbances may lead to other metabolic and hormonal changes, such 
as impairment in glucose tolerance (Spiegel et al., 1999). Insulin sensitivity is closely linked 
to the serum levels of sex steroids. Women with impairment in glucose tolerance or type 
2  diabetes  had  significantly  higher  total  and  bioavailable  estradiol  levels  than  those  with 
normal glucose tolerance (Goodman-Gruen and Barrett-Connor, 2000). 
Furthermore,  the  sleep-debt  condition  in  comparison  to  the  fully  rested  condition 
contributes to a disruption (diminishing) of thyrotropin concentrations (Spiegel et al., 1999). It 
was  noticed  that  TSH  was  lower  in  fertile  than  in  infertile  patients  and  low  TSH 
concentrations negatively correlated with E2 in the luteal phase (Gerhard et al., 1991). In 
addition,  thyroid  hormones  were  found  in  human  follicular  fluid  and  thyroid  hormone 
receptors  in  human  granulosa  cells  (Wakim  et  al.,  1993),  suggesting  that  they  might 
participate in direct regulation of reproductive function in women. It is well known, that 
thyroid  disorders  may  be  connected  with  menstrual  abnormalities  (Krassas,  2000)  and 
reproductive failure such as infertility, pregnancy wastage and stillbirths (Joshi et al., 1993). The results of our study suggest that lower levels of E2 in women, who sleep regularly, 
may be one of the mechanisms responsible for the observed relationship between night shift 
work and breast cancer in women. Therefore, sleep variation may represent one of modifiable 
risk factors for breast cancer. It may be possible to lower the individual risk of this disease by 
maintaining more regular circadian rhythm pattern, which may lead to lower lifetime levels of 
estradiol and thus to reduced risk of breast cancer.  
The  strength  of  our  study  is  that  estradiol  levels  were  measured  in  saliva  samples 
collected daily for one entire menstrual cycle by each participant, together with information 
on number of sleeping hours per night. That methodology allows for the precise and reliable 
assessment  of  steroids  levels  (Jasienska  and  Jasienski,  2007)  and  fluctuations  in  sleep 
duration.  
Because  this  is  the  first  study  that  has  shown  a  positive  association  between  sleep 
variation and estradiol levels in healthy women of reproductive age, after controlling for sleep 
duration,  further  studies  are  needed  to  confirm  these  findings.  Additional  basic  science 
research is also required to identify and determine the mechanisms between sleep irregularity 
and estradiol levels. 
 
Acknowledgements 
We are grateful to the women who participated in this study, to students of the Faculty 
of Public Health, Jagiellonian University who worked as research assistants and Dr. Mary 
O'Rourke from Harvard University. This study was supported by Polish State Committee for 
Scientific Research (to GJ) and Norwegian Cancer Society. 
 
 
Bibliography 
 
1.  Bernstein L, Yuan JM, Ross RK, Pike MC, Hanisch R, Lobo R, Stanczyk F, et al. (1990). Serum hormone 
levels in pre-menopausal Chinese women in Shanghai and white women in Los Angeles: results from two 
breast cancer case-control studies. Cancer Causes Control 1:51-8. 
2.  Brzezinski A, Seibel MM, Lynch HJ, Deng M-H, Wurtman RJ (1987). Melatonin in human preovulatory 
follicular fluid. J Clin Endocrinol Metab 64:865–867. 
3.  Cauley JA, Lucas FL, Kuller LH, Stone K, Browner W, Cummings SR. Elevated serum estradiol and 
testosterone  concentrations are  associated with  a high risk for breast  cancer (1999). Ann Intern  Med 
130:270-277. 4.  Cella  F,  Giordano  G,  Cordera  R.  (2000).  Serum  leptin  concentrations  during  the  menstrual  cycle  in 
normal-weight women: effects of an oral triphasic estrogen-progestin medication. Eur J Endocrinol 2:174-
8.  
5.  Cohen M, Lippman M, Chabner B. (1978). Role of pineal gland in aetiology and treatment of breast 
cancer. Lancet  8094:814-6.  
6.  Cos S, Sanchez-Barcelo´ EJ (2000). Melatonin – experimental basis for a possible application in breast 
cancer prevention and treatment. Histol Histopathol 15:637–647. 
7.  Davis S, Mirick DK., Stevens RG. (2001). Night shift work, light at night, and risk of breast cancer. J Natl 
Cancer Inst 20:1557-1562. 
8.  Feychting M, Osterlund B, Ahlbom (1998). A Reduced cancer incidence among the blind. Epidemiology 
5:490-4. 
9.  Furberg AS, Jasienska G, Bjurstam N, Torjesen PA, Emaus A, Lipson SF, Ellison PT, Thune I. (2005). 
Metabolic and hormonal profiles: HDL cholesterol as a plausible biomarker of breast cancer risk. the 
norwegian EBBA study. Cancer Epidemiol Biomarkers Prev 14:33-40. 
10.  Goodman-Gruen, Barrett-Connor (2000). Sex differences in the association of endogenous sex hormone 
levels and glucose tolerance status in older men and women. Diabetes Care 7: 912-918. 
11.  Hahn RA. (1991). Profound bilateral blindness and the incidence of breast cancer. Epidemiology 3:208-
10. 
12.  Hankinson SE, Willett WC, Manson JE, Colditz GA, Hunter DJ, Spiegelman D, Barbieri RL, Speizer FE. 
(1998). Plasma sex steroid hormone levels and risk of breast cancer in postmenopausal women. J Natl 
Cancer Inst 17:1292-9.  
13.  Hansen  J.  (2001).  Increased  breast  cancer  risk  among  women  who  work  predominantly  at  night. 
Epidemiology 1:74-7. 
14.  Hansen MA, Garde HA, Hansen J. Diurnal urinary 6-sulfatoxymelatonin levels among healthy Danish 
nurses during work and leisure time. Chronobiol Int 2006 6:1203-15. 
15.  Hasler  G,  Buysse  DJ,  Klaghofer  R,  Gamma  A,  Ajdacic  V,  Eich  D,  Rossler,  Angst  J.  (2004).  The 
association between short sleep duration and obesity in young adults: a 13-year prospective study. Sleep 
4:661-6. 
16.  Henderson BE, Ross RK, Bernstein L. (1988) Estrogens as a cause of human cancer: The Richard and 
Hinda Rosenthal Foundation Award Lecture. Cancer Res 48:246.  
17.  Hollander LE., Freeman EW., Sammel MD., Berlin JA., Grisso JA, Battistini M (2001). Sleep quality, 
estradiol levels, and behavioral factors in late reproductive age women. Obstet Gynecol 98:391-397. 
18.  Jasienska G, Ellison PT. (2004). Energetic factors and seasonal changes in ovarian function in women 
from rural Poland. Am J Hum Biol 16: 1-18. 
19.  Jasienska  G.,  Jasienski  M.  (2007).  Interpopulation,  interindividual,  intercycle,  and  intracycle  natural 
variation  in  progesterone  levels:  a  quantitative  assessment  and  implications  for  population  studies. 
American Journal of Human Biology (in press). 
20.  Jasienska G, Thune I. (2001). Lifestyle, hormones, and risk of breast cancer. Br Med J 322:586-7. 
21.  Jasienska  G,  Ziomkiewicz  A,  Thune  I,  Lipson  S,  Ellison  PT.  (2006).  Habitual  physical  activity  and 
estradiol levels in women of reproductive age. Eur J Cancer Prev 15:439–445. 22.  Joshi JV, Bhandarkar SD, Chadha M, Balaiah D, Shah R. (1993). Menstrual irregularities and lactation 
failure may precede thyroid dysfunction or goitre. J Postgrad Med 39:137-41. 
23.  Kauppila A, Kivela A, Pakarinen A, Vakkuri O. (1987). Inverse seasonal relationship between melatonin 
and ovarian activity in humans in a region with a strong seasonal contrast in luminosity. J Clin Endocrinol 
Metab 5:823-8. 
24.  Kiejna A, Rymaszewska J, Wojtyniak B, Stokwiszewski J. (2004). Characteristics of sleep disturbances in 
Poland – results of the National Health Interview Survey. Acta Neuropsychiatrica 16:124–129. 
25.  Kliukiene J, Tynes T, Andersen A. (2001). Risk of breast cancer among Norwegian women with visual 
impairment. Br J Cancer. 3:397-9. 
26.  Krassas GE. (2000). Thyroid disease and female reproduction. Fertil Steril 6:1063-70. 
27.  Leon-Blanco MM, Guerrero JM, Reiter  RJ,  Calvo JR, Pozo D. (2003). Melatonin inhibits telomerase 
activity in the MCF-7 tumor cell line both in vivo and in vitro. J Pineal Res 3:204. 
28.  Leproult R, Copinschi G, Buxton O, Van Cauter E. (1997). Sleep loss results in an elevation of cortisol 
levels the next evening. Sleep 10:865-70. 
29.  Lewy AJ, Wehr TA, Goodwin FK, Newsome DA, and Markey SP. (1980). Light suppresses melatonin 
secretion in humans. Science 4475:1267-1269. 
30.  Malpaux B, Migaud M, Tricoire H, and Chemineau P (2001). Biology of mammalian photoperiodism and 
the critical role of the pineal gland and melatonin. J Biol Rhythms 16: 336–347. 
31.  Mannucci E, Ognibene A, Becorpi A, Cremasco F, Pellegrini S, Ottanelli S, Rizzello SM, et al. (1998). 
Relationship between leptin and oestrogens in healthy women. Eur J Endocrinol 2:198-201. 
32.  Mayo JC, Sainza RM, Antolína I, Herreraa F, Martin V,  Rodrigueza C. (2002). Melatonin regulation of 
antioxidant enzyme gene expression. Cell Mol Life Sci 59:1706–1713. 
33.  Missmer SA., Eliassen A.H, Barbieri RL, Hankinson SE. (2004). Endogenous estrogen, androgen, and 
progesterone concentrations and breast cancer risk among postmenopausal women. J Natl Cancer Inst 
24:1856-1865. 
34.  Pawlikowski  M,  Kolomecka  M,  Wojtczak  A,  Karasek  M.  (2002).  Effects  of  six  months  melatonin 
treatment on sleep quality and serum concentrations of estradiol, cortisol, dehydroepiandrosterone sulfate, 
and somatomedin C in elderly women. Neuro Endocrinol Lett 23 Suppl 1:17-9. 
35.  Pinheiro SP, Schernhammer  ES,  Tworoger SS,  Michels KB. (2006). A prospective study on habitual 
duration of sleep and incidence of breast cancer in a large cohort of women. Cancer Res 66: 5521-5525. 
36.  Ram PT, Kiefer T, Silverman M, Song Y, Brown GM, Hill SM. (1998). Estrogen receptor transactivation 
in MCF-7 breast cancer cells by melatonin and growth factors. Mol Cell Endocrinol 141(1-2):53-64.  
37.  Rodriguez AB, Marchena JM, Nogales G, Duran J, Barriga C. (1999). Correlation between the circadian 
rhythm of melatonin, phagocytosis, and superoxide anion levels in ring dove heterophils. J Pineal Res 
1:35-42. 
38.  Ronkainen  H,  Pakarinen  A,  Kirkinen  P,  Kauppila  A.  (1985).  Physical  exercise-induced  changes  and 
season-associated differences in the pituitary-ovarian function of runners and joggers. J Clin Endocrinol 
Metab 3:416-22. 39.  Ronnberg  L,  Kauppila  A,  Leppaluoto  J,  Martikainen  H,  Vakkuri  O.  (1990).  Circadian  and  seasonal 
variation in human preovulatory follicular fluid melatonin concentration. J Clin Endocrinol Metab 2:492-
6. 
40.  Schernhammer  ES,  Laden  F,  Speizer  FE,  Willett  WC,  Hunter  DJ,  Kawachi  I,  Colditz  GA.  (2001). 
Rotating night shifts and risk of breast cancer in women participating in the nurses' health study. J Natl 
Cancer Inst. 20:1563-8. 
41.  Schernhammer RB, Willett WC. Laden F, Colditz GA, Hankinson SE. (2004). Epidemiology of urinary 
melatonin in women and its relation to other hormones and night work. Cancer Epidemiol Biomarkers 
Prev 13: 936-943. 
42.  Davis S, Mirick DK, Stevens RG (2001). Night shift work, light at night, and risk of breast cancer. J Natl 
Cancer Inst 20:1557-1562. 
43.  Shimizu  H,  Ross  RK,  Bernstein  L,  Pike  MC,  Henderson  BE  (1990).  Serum  oestrogen  levels  in 
postmenopausal women: comparison of American whites and Japanese in Japan. Br J Cancer 3:451-3. 
44.  Singh M, Drake CL, Roehrs T, Hudgel DW, Singh TR et al. (2005). The association between obesity and 
short sleep duration: A population- Based study. J Clin Sleep Med 4:357 – 363. 
45.  Stevens RG (2006). Artificial lighting in the industrialized word: circadian disruption and breast cancer. 
Cancer Causes Control 17:501-507. 
46.  Taheri S, Lin L, Austin D, Young T, Mignot E. (2004). Short sleep duration is associated with reduced 
leptin, elevated ghrelin, and increased body mass index. PLoS Med 3: 210-217. 
47.  Tamarkin  L,  Baird  CJ,  Almeida  OF  (1985).  Melatonin:  a  coordinating  signal  for  mammalian 
reproduction? Science 227: 714–720. 
48.  Tamarkin  L,  Danforth  D,  Lichter  A,  DeMoss  E,  Cohen  M,  Chabner  B,  and  Lippman  M.  (1982). 
Decreased nocturnal plasma melatonin peak  in patients with  estrogen receptor positive breast  cancer. 
Science 4549:1003-1005. 
49.  Verkasalo PK, Lillberg K, Stevens RG., Hublin C, Partinen M, Koskenvuo M, Kaprio J. (2005). Sleep 
duration and breast cancer: a prospective cohort study. Cancer Res 65:9595-9600. 
50.  Wakim AN, Polizotto SL, Buffo MJ, Marrero MA, Burholt DR. (1993). Thyroid hormones in human 
follicular fluid and thyroid hormone receptors in human granulosa cells. Fertil Steril 6:1187-90. 
51.  Wauters M, Considine R, Van Gaal L. (2000). Human leptin: from an adipocyte hormone to an endocrine 
mediator. Eur J Endocrinol 143:293-311. 
52.  Woo MM,  Chen-Jei T, Keun Kang S, Nathwani PS, Fun Pang S, Leung P. (2001). Direct Action of 
melatonin in human granulosa-luteal cells. J Clin Endocrinol Metab 10:4789-4797. 
53.  Yie SM,  Brown GM,  Liu GY,  Collins JA,  Daya  S, Hughes EG, Foster  WG, Younglai  EV. (1995a). 
Melatonin and steroids  in human pre-ovulatory follicular  fluid: seasonal variations and granulosa cell 
steroid production. Hum Reprod 1:50-55. 
54.  Yie SM, Niles LP, Younglai EV. (1995b). Melatonin receptors on human granulosa cell membranes. J 
Clin Endocrinol Metab 80:1747–1749. 
55.  Yu H, Shu XO, Shi R, Dai Q, Jin F, Gao YT, Li BDL, Zheng W. (2003). Plasma sex steroid hormones 
and breast cancer risk in Chinese women. Int J Cancer 105:92–97. 56.  Wehr TA. (1991). The durations of human melatonin secretion and sleep respond to changes in daylength 
(photoperiod). J Clin Endocrinol Metab 6:1276-80.  
 
 
 
   
 